• Aspirin's 'double hit' on bowel cancer

    Updated: 2012-05-31 10:32:00
    Aspirin kills cancer cells by controlling two key processes that influence energy use in cells and could explain how aspirin can prevent bowel cancer.

  • Pre-op Treatments Boost Survival for Esophageal Cancer Patients Study

    Updated: 2012-05-31 09:40:07
    : Health News Pre-op Treatments Boost Survival for Esophageal Cancer Patients : Study Print E-mail WEDNESDAY , May 30 HealthDay News Patients with esophageal cancer who receive chemotherapy and radiation before surgery have better outcomes , Dutch researchers . report We think that patients with esophageal cancer have the best chance to survive this cancer when they are treated with preoperative chemo-radiotherapy followed by surgery , said lead researcher Dr . Ate van der Gaast , from the medical oncology department at Erasmus University Hospital in Rotterdam . By giving preoperative chemo-radiotherapy , more patients are cured than with surgery alone . In the United States , more than 17,000 people will be diagnosed with esophageal cancer and more than 15,000 will die from it this year ,

  • Cancer Research UK initiative attracts innovative targeted cancer trials to the UK

    Updated: 2012-05-31 00:01:00
    A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

  • Cutting alcohol intake 'would prevent 2,600 cancer deaths a year'

    Updated: 2012-05-30 23:30:00
    Reducing daily alcohol intake could prevent 4,600 deaths every year, including more than 2,600 from cancer, experts from Oxford University have said.

  • Blood test gives 'real-time' picture of cancer

    Updated: 2012-05-30 19:00:00
    A simple and cost-effective blood test could be used to monitor how a patient is responding to treatment and detect genetic faults in their cancer as they happen, according to a Cancer Research UK study.

  • Breaking News- MDV-3100 Starts an Expanded Access Program in the United States

    Updated: 2012-05-30 16:17:46
    Medivation and Astellas Announce Initiation of Expanded Access Program for Enzalutamide (MDV3100) in the United States for men with metastatic prostate cancer previously treated with chemotherapy. Medivation, Inc. and Astellas Pharma Inc. today announced that they have come to an agreement with the U.S. Food and Drug Administration (FDA) which will allow them to proceed [...]

  • At the AUA Meeting – Does Provenge Provide Better Survival Numbers?

    Updated: 2012-05-30 14:50:38
    The recent AUA meetings in Atlanta had a number of interesting abstracts presented that concern men with advanced prostate cancer. Some of the more interesting abstracts were look back analysis of sipuleucel-T (Provenge) done by consultants for Dendreon, the company who manufactures Provenge. They took the data from the al three of the phase III [...]

  • Happy Oncology Nursing Month!

    Updated: 2012-05-30 06:14:00
    About Us Sponsored : by CTCA Cancer News Many Primary Care Docs Don't Know Long-Term Effects of Chemo : Survey Experts stress that information needs to be passed on after cancer treatment ends Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition

  • Emotional Woes May Last for Childhood Cancer Survivors

    Updated: 2012-05-30 03:21:30
    Health News Emotional Woes May Last for Childhood Cancer Survivors Print E-mail TUESDAY , May 29 HealthDay News Adult survivors of childhood cancer can suffer emotional problems and reduced quality of life because of the long-term physical effects of their cancer treatment , a new study . finds Researchers used data from the Childhood Cancer Survivor Study to assess the effects of scarring , disfigurement and persistent hair loss experienced by more than 14,000 adult survivors of childhood cancer . The survivors were compared to siblings who did not have childhood . cancer Survivors with persistent hair loss had an increased risk of anxiety female survivors with persistent hair loss had an increased risk of depressive symptoms and survivors with a head or neck , arm or leg disfigurement

  • Protein could be specific marker for prostate cancer

    Updated: 2012-05-30 00:01:00
    A newly-discovered protein found only in prostate cancer cells could be used as a marker of the disease and offer a new treatment target, according to a study in the British Journal of Cancer.

  • Education May Protect Brain From Exposure to Solvents

    Updated: 2012-05-29 19:20:46
    Health News Education May Protect Brain From Exposure to Solvents Print E-mail TUESDAY , May 29 HealthDay News People with less than a high school education who work with solvents may have problems with their thinking skills later in life , according to a study of people in . France In the study , researchers from Harvard University noted that people with more education did not experience the same types of issues with their thinking , or so-called cognitive , skills , even if they had the same amount of exposure to these . chemicals People with more education may have a greater cognitive reserve that acts like a buffer , allowing the brain to maintain its ability to function in spite of damage , study author Lisa Berkman , of Harvard University in Cambridge , Mass . said in news release

  • Scientists hail largest-ever release of childhood cancer genome data

    Updated: 2012-05-29 17:43:00
    The largest-ever release of childhood cancer genome data has been announced by US researchers.

  • Night Shift Might Boost Women's Breast Cancer Risk Study

    Updated: 2012-05-29 11:20:10
    : Health News Night Shift Might Boost Women's Breast Cancer Risk : Study Print E-mail MONDAY , May 28 HealthDay News Women who work the night shift more than twice a week might be increasing their risk for breast cancer , Danish researchers . find Moreover , the risk appears to be cumulative and highest among women who describe themselves as morning people rather than evening people , the researchers . say About 10 to 20 percent of women in modern societies have night shift work , said lead researcher Johnni Hansen . It might therefore be one of the largest occupational problems related to cancer . Right now , the reasons for these findings are . uncertain Night shift work involves exposure to light at night , which decreases the production of the night hormone melatonin that seems to

  • Gene link to higher rates of bowel cancer in men

    Updated: 2012-05-27 18:00:00
    Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.

  • PodMed: A Medical News Roundup from Johns Hopkins

    Updated: 2012-05-25 22:36:01
    This week's topics include the benefits of flexible sigmoidoscopy, dangers of calcium supplements, diabetic foot ulcers, and PSA screening.

  • On the Horizon – TOK-001 (Galeterone)

    Updated: 2012-05-25 18:41:54
    Tokai, a Cambridge, MA based Pharmaceutical company, just presented a promising set of Phase I data pointing to the early efficacy of its “triple whammy” pill for castration-resistant prostate cancer, TOK-001 or galeterone. In their phase 1 trial the PSA levels in about half of the 49 men in the dose-ranging study declined 30% or [...]

  • Anti-psychotic drug gives clues to target cancer 'stem cells'

    Updated: 2012-05-25 11:34:00
    A key type of cancer cell that drives tumours' growth can be neutralised without damaging healthy cells, according to researchers in Canada.

  • Zytiga – When Should We Discontinue Using It?

    Updated: 2012-05-24 17:22:33
    I have had a number of recent conversations with men with advanced prostate cancer who have been taking Abiraterone Acetate (Zytiga). The question that comes up in regular conversation is about knowing when Zytiga has stopped working or when Zytiga should be discontinued. All the real guidance we have to answer this question comes from [...]

  • ASCO: Stage IV Cancer Often Not Treated

    Updated: 2012-05-23 22:58:21
    CHICAGO -- One patient in five who presents with a stage IV solid-tumor cancer does not receive treatment directed at the cancer, researchers found.

  • Single PSA Test Predicts Prostate Cancer Risk

    Updated: 2012-05-23 21:13:05
    ATLANTA -- A baseline prostate-specific antigen value of less than 1 ng/mL predicted a low risk of prostate cancer over the next 15 years in men younger than 50, a study showed.

  • A New Genetic Technique Predicts Prostate Cancer Relapse

    Updated: 2012-05-23 17:08:02
    According to a study published online May 9 in The American Journal of Pathology copy number variations (CNV) in both malignant and benign prostate tissue is predictive of prostate cancer relapse. The research performed at the University of Pittsburgh School of Medicine by Yan P. Yu, M.D. and colleagues evaluated whether CNV of the genomes [...]

  • Increasing symptom awareness could improve cancer survival in men with mental illness

    Updated: 2012-05-23 12:01:00
    Men suffering from psychiatric problems when diagnosed with cancer are more likely to die from the disease, according to a new study published today in the British Journal of Cancer.

  • Shelved sleep disorder drug neutralises 'undruggable' cancer cells

    Updated: 2012-05-23 01:10:00
    US scientists have used an abandoned sleep disorder drug to target a cancer protein in mice that was previously considered 'undruggable'.

  • Many Think Cancer Spreads by Air

    Updated: 2012-05-22 23:14:51
    ATLANTA -- One in six prostate cancer patients believed that cancer can be spread by air, and that belief may affect their treatment choices, results of a patient survey showed.

  • Urologists Pan Task Force PSA Ruling

    Updated: 2012-05-22 22:42:56
    ATLANTA -- The last word on prostate cancer screening has neither been written nor spoken, according to urologists who registered objections to a recommendation that PSA testing should not be routine for healthy men in this ALLMedPage Today video feature.

  • Twitter Emerges as Health Policy Sounding Board

    Updated: 2012-05-22 20:55:14
    ATLANTA -- Social media's potential to influence health policy showed up early in the debate over PSA measurement as a screening test for prostate cancer, according to study reported here.

  • Study confirms 'flexi scope' test reduces bowel cancer deaths

    Updated: 2012-05-22 11:41:00
    A bowel cancer screening test, soon to be introduced in England, reduces the number of new cases and deaths from the disease, a US study has confirmed.

  • Robot Adds $6K to Prostate Surgery Cost

    Updated: 2012-05-22 05:28:36
    ATLANTA -- Robotic-assisted radical prostatectomy cost 60% more than an open procedure, a difference driven primarily by higher operating-room costs, according to a study reported here.

  • The U.S. Preventive Services Task Force (USPSTF) Down Grades PSA Testing

    Updated: 2012-05-22 00:55:32
    Today, the U.S. Preventive Services Task Force (USPSTF) posted its prostate cancer screening final recommendation statement. The following letter was received by anyone who posted a public comment: The USPSTF is committed to making the recommendations process clear and transparent and we are able to achieve that by keeping the public fully informed throughout the [...]

  • Recommendation Against Use of PSA Sends Early Detection Backwards

    Updated: 2012-05-21 22:06:33
    WAPC Responds to USPSTF Final Recommendation on PSA Screening Washington, DC, May 21, 2012 – The U.S. Preventive Services Task Force issued a “D” recommendation against the use of PSA screening in the detection of prostate cancer.  Women Against Prostate Cancer is deeply disappointed in today’s announcement and the detriment that it will cause to [...] No related posts.

  • Prevention Panel: No Need for PSA Test

    Updated: 2012-05-21 22:00:00
    Men should no longer have PSA measurements as a screening test for prostate cancer, according to a final recommendation from the United States Preventive Services Task Force.

  • More Information on the Expanded Access Trial for Alpharadin (Radium-223)

    Updated: 2012-05-20 22:28:21
    Radium-223 Chloride (Alpharadin) is now available for the treatment of men with advanced prostate cancer who have symptomatic bone metastases (painful) and who are also castration-resistant (hormone-refractory). This is an expanded access program that will allow the use of Alpharadin prior to the formal FDA approval of the treatment. From the Clinical Trials Web Page [...]

  • Experimental drug could target melanoma that spreads to brain

    Updated: 2012-05-18 00:01:00
    A new drug could be effective for the treatment of melanoma that has spread to the brain, according to an early-stage clinical trial.

  • Good News – We Have Made It Over Another Funding Hurdle for the Department of Defense Medical Research Program for Fiscal 2013

    Updated: 2012-05-17 17:18:44
    Yesterday May 16, 2012, the House Appropriations Committee released their draft committee report to accompany the FY13 Defense Appropriations Act. This draft included the CDMRP requested budget for 2013. The good news is that the ask includes $80 million dollars for the Prostate Cancer Research Program. Although this is the same amount prostate cancer received [...]

  • New Data Indicates That Provenge Works Best In Men With Lower PSA Scores

    Updated: 2012-05-17 03:19:33
    Today, May 16, 2012, Dendreon, the makers of Provenge, disclosed a new analysis of data of its pivotal 512-patient study of men with castrate resistant prostate cancer who received sipuleucel-T (Provenge). The new analysis separated the men in the study into four quartiles based on their prostate-specific antigen (PSA) scores. The initial design of the [...]

  • Cancer Research UK to investigate new drug combination in lung cancer

    Updated: 2012-05-17 00:01:00
    Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth.

  • ASCO: Drug Before Surgery Clears Prostate Cancer

    Updated: 2012-05-16 23:39:31
    CHICAGO -- A third of men with localized, high-risk prostate cancer achieved pathologic complete response or near-complete response following neoadjuvant therapy with abiraterone and an LHRH agonist, results of a preliminary clinical study showed.

  • Study uncovers genetic diversity of breast cancer

    Updated: 2012-05-16 17:56:00
    Nine new genes involved in the development of breast cancer have been uncovered by Cambridge researchers, bringing the total number to at least 40.

  • Don’t Neglect Your Skin This Summer

    Updated: 2012-05-16 16:06:00
    About Us Sponsored : by CTCA Cancer News Exercise May Boost Survival in Breast , Colon Cancer Patients Review looked at six decades of studies on cancer , physical activity Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet Recipes

  • NICE recommends prostate cancer drug abiraterone

    Updated: 2012-05-16 00:01:00
    The National Institute for Health and Clinical Excellence (NICE) has issued new draft guidance recommending the use of previously rejected prostate cancer drug abiraterone (Zytiga) on the NHS.

  • Public Health Web for May 2012

    Updated: 2012-05-15 07:36:14
    Public Health Web for May 2012 is about Health Directory & Resource. Public Health Web provides numerous links to human health issues, including diseases and conditions, medications, sexual health, fitness, nutrition, reference, and news. It also includes specific issues of women, men, children and seniors.

  • Premature deaths from cancer in the UK fall below 14,000 for middle age

    Updated: 2012-05-15 00:01:00
    The number of people in their 50s dying prematurely from cancer in the UK has fallen below 14,000 for the first time in 40 years according to new Cancer Research UK figures published today.

  • Cancer patients seek reassurance through nurse helplines

    Updated: 2012-05-14 00:01:00
    A survey by Cancer Research UK’s helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.

  • NICE recommends new targeted lung cancer treatment

    Updated: 2012-05-10 17:29:00
    A new treatment for a type of non-small-cell lung cancer (NSCLC) has been made available on the NHS.

  • Whole-genome sequencing uncovers new skin cancer gene

    Updated: 2012-05-09 18:49:00
    US scientists have used high-tech DNA sequencing to uncover a new gene linked to melanoma – the most serious form of skin cancer

  • One in six worldwide cancers down to 'largely preventable or treatable' infection

    Updated: 2012-05-09 00:01:00
    Around one in six worldwide cancers - two million new cases every year - are caused by infections, according to a French study.

  • Genetic variation 'predicts behaviour of prostate cancer'

    Updated: 2012-05-08 15:55:00
    Measuring a type of genetic variation in the blood of men with prostate cancer could help predict how their disease will develop, according to US research.

  • Limit PSA Tests to Younger Men, These Docs Say

    Updated: 2012-05-07 20:27:24
    Healthy younger men should be screened regularly for prostate cancer using prostate-specific antigen testing, but older men in poor health should not be, researchers suggested.

  • The Signs of Prostate Cancer

    Updated: 2012-05-07 12:04:51
    Most men will show some symptom of prostate cancer before their doctor will give them an official diagnosis. Knowing what to look for can help you to determine if you need to contact your doctor and to have your prostate health examined. Prostate Cancer Symptoms If you have prostate cancer it is likely that you [...]

  • Trial launched into curry chemical’s cancer-fighting properties

    Updated: 2012-05-07 00:01:00
    Compounds found in curry are being investigated as a way of improving drug response in patients with advanced bowel cancer in a new study launched today (Monday).

  • Lab Notes: Skin Immune Cells Swing Both Ways

    Updated: 2012-05-04 22:01:25
    Langerhans cells in the skin may suppress excess immune activity or direct attacks on invaders, depending on which is needed. Also this week: a possible common target for multiple pathogens.

  • Department of Health and medical charities publish guidelines on research funding

    Updated: 2012-05-04 12:00:00
    New guidelines that establish how the Department of Health (DH) supports charity-funded research in the NHS have been published.

  • Prostate cancer cases hit 40,000 for the first time

    Updated: 2012-05-04 00:01:00
    Latest figures from Cancer Research UK reveal that the number of men diagnosed with prostate cancer in the UK has risen above 40,000.

Current Feed Items | Previous Months Items

Apr 2012 | Mar 2012 | Feb 2012 | Jan 2012 | Dec 2011 | Nov 2011